Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia
Condition(s):HyperammonemiaLast Updated:November 18, 2023Completed
Hide Studies Not Open or Pending
Condition(s):HyperammonemiaLast Updated:November 18, 2023Completed
Condition(s):DiverticulitisLast Updated:September 8, 2023Recruiting
Condition(s):Adverse Drug InteractionsLast Updated:September 6, 2019Completed
Condition(s):Crohn’s DiseaseLast Updated:November 14, 2018Completed
Condition(s):HealthyLast Updated:March 19, 2010Completed
Condition(s):Immune Reconstitution Inflammatory Syndrome; Immune Reconstitution Syndrome; Tuberculosis; HIV-infection/AidsLast Updated:November 25, 2013Withdrawn
Condition(s):Children With Confirmed HIV Infection; Receiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard Dose; Successfully Completed TB Treatment in the Past 2 to 6 Weeks of EnrollmentLast Updated:December 14, 2010Unknown status
Condition(s):HIV Infection; TuberculosisLast Updated:October 11, 2018Completed
Condition(s):Tuberculosis, PulmonaryLast Updated:July 19, 2023Completed
Condition(s):Latent Tuberculosis; Human Immunodeficiency Virus; Rifamycins Causing Adverse Effects in Therapeutic Use; Drug Interaction PotentiationLast Updated:March 27, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.